GlassScriptPhysician profile
Shawna Lee Boyle
NPI 1518347913
$1,464.89
in general payments reported to CMS, 2019-2025
22 companies · $83.22 in 2025
The $83.22 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2021: $121 · 2022: $797 · 2023: $184 · 2024: $145 · 2025: $83.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $207.64 | 2023-2024 | Bard Urinary Drainage Bag |
| Axonics, INC. | $205.75 | 2022 | |
| Janssen Biotech, INC. | $113.56 | 2019-2022 | |
| Urogen Pharma, INC. | $112.28 | 2021-2024 | |
| Astellas Pharma US INC | $108.28 | 2019-2022 | |
| Boston Scientific Corporation | $107.61 | 2022 | |
| Progenics Pharmaceuticals, INC. | $96.84 | 2022 | |
| Abbvie INC. | $76.04 | 2021-2025 | |
| Rochester Medical Corporation | $63.44 | 2022 | |
| Urovant Sciences INC | $55.87 | 2022 | |
| Myriad Genetic Laboratories, INC. | $42.34 | 2022-2024 | Prolaris |
| Medtronic, INC. | $38.60 | 2022 | |
| Teleflex LLC | $27.49 | 2022 | |
| Sumitomo Pharma America, INC. | $27.40 | 2024 | Gemtesa |
| Procept Biorobotics Corporation | $27.25 | 2024 | Aquabeam System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $26.66 | 2024 | |
| Myovant Sciences INC. | $24.60 | 2022 | |
| Endo USA, INC. | $24.46 | 2025 | Xiaflex |
| Olympus America INC. | $24.43 | 2025 | Itind System |
| Pfizer INC. | $23.86 | 2022 | |
| Convatec INC. | $15.81 | 2025 | |
| Smith+Nephew, INC. | $14.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawna Boyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.